Pharmafile Logo

Vaccine hesitancy eBook

June 7, 2021 | #COVID19, coronavirus, vaccines 

In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.

- PMLiVEToday, all eyes are on vaccines. At its high, the US administered 3.4 million doses of the COVID-19 vaccines per day, but in April, this number dwindled to 2.2 million per day. The vulnerable and those who passionately support the vaccines had queued up to become the first to be immunized, sometimes driving hours to get their shot.

However, now that the most enthusiastic populations have been vaccinated, life science companies, healthcare professionals, and the government are up against the challenging task of coaxing the 31% of Americans who are vaccine-hesitant into signing up for the vaccine.

States, corporations, and vaccination centers are even offering incentives from doughnuts and free beer, to savings bonds and marijuana to stimulate demand for vaccines.

In this downloadable pack, we interview industry-leading stakeholders and provide expert analysis from our consultants and commercial experts. Download the PDF to explore:

  • Original research findings on the deeper drivers behind vaccine hesitancy and the benefits of taking a human-centred approach for increasing vaccine uptake
  • The current landscape, expert analysis, and advice for improving vaccine uptake
  • The motivations behind the Arm in Arm campaign, a global campaign designed to encourage donations to ensure everyone across the globe has access to a lifesaving COVID-19 vaccine
  • The social and political drivers fuelling the anti-vax movement
  • The differences between the US and UK immunization programs
  • Why our consultants are volunteering to be part of the UK immunization program

DOWNLOAD THE EBOOK HERE

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic

Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals how life...

Healthcare tech: the driving force behind value-based care?

In 2020, healthcare technology investment went into overdrive. We speak to Sunny Kumar, Partner at GSR Ventures, to find out how COVID‑19 has transformed the industry and whether healthcare technology...

Numbers, navigation, and narratives: digital storytelling in medical communications

Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...

Building the hospital of the future

Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience.

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.

The rise of the healthcare social media influencer

The consumer industry has long been leveraging the power of social media influencers with enormous success. But can the highly regulated healthcare industry achieve the same results? Daniel Brackins explores...

Vaccine hesitancy eBook

In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.

Deep 6 AI: the smart software breathing new life into clinical trials

Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention.

Are you ready for the digital health revolution?

In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age.